Verve Therapeutics(VERV) - 2023 Q1 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 VERVE THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) 201 Brookline Avenue, Suite 601 Boston, Massachusetts 02215 (Address of principal executive offices) (Zip Code) Delaware 82-4800132 (I.R.S. Employer Identification No.) For the quarterly p ...